Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test

European Journal of Endocrinology

Volumn 169, Issue 2, 2013, Pages 255-261

  Pepe, Jessica ^a   Curione, Mario ^a   Morelli, Sergio ^a   Varrenti, Marisa ^a   Cammarota, Camillo ^b   Cilli, Mirella ^a   Piemonte, Sara ^a   Cipriani, Cristiana ^a   Savoriti, Claudio ^a   Raimo, Orlando ^a   De Lucia, Federica ^a   Colangelo, Luciano ^a   Clementelli, Carolina ^a   Romagnoli, Elisabetta ^a   Minisola, Salvatore ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION;

AGED; ARRHYTHMIAS, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MIDDLE AGED; PARATHYROIDECTOMY; STATISTICS, NONPARAMETRIC; VENTRICULAR PREMATURE COMPLEXES;

EID: 84880932962     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0293     Document Type: Article

References (35)

1. Hedback G & Odén A. Increased risk of death from primary hyperparathyroidism an update. European Journal of Clinical Investigation 1998 4 271-276. (doi:10.1046/j.1365-2362. 1998.00289.x)
2. Yu N, Donnan PT, Flynn RW, Murphy MJ, Smith D, Rudman A & Leese GP. Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clinical Endocrinology 2010 73 30-34.
3. Pepe J, Curione M, Morelli S, Colotto M, Varrenti M, Castro C, D'Angelo A, Cipriani C, Piemonte S, Romagnoli E et al. Arrhythmias in primary hyperparathyroidism evaluated in exercise test. European Journal of Clinical Investigation 2013 43 208-214. (doi:10.1111/eci.12038)
4. Pepe J, Cipriani C, Pilotto R, De Lucia F, Castro C, Lenge L, Russo S, Guarnieri V, Scillitani A, Carnevale Vet al. Sporadic and hereditary primary hyperparathyroidism. Journal of Endocrinological Investigation 2011 34 (7 Suppl) 40-44.
5. Nattel S & Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: Mechanistic insights and therapeutic opportunities. European Heart Journal 2012 33 1870-1877. (doi:10.1093/eurheartj/ ehs079)
6. Lind L & Ljunghall S. Serum calcium and the ECG in patients with primary hyperparathyroidism. Journal of Electrocardiology 1994 27 99-103. (doi:10.1016/S0022-0736(05)80092-5)
7. Zhang Y, Post WS, Dalal D, Bansal S, Blasco-Colmenares E, Jan De Beur S, Alonso A, Soliman EZ, Whitsel EA, Brugada R et al. Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: Findings from NHANES III and ARIC. Journal of Clinical Endocrinology and Metabolism 2011 96 1873-1882. (doi:10.1210/jc.2010-2969)
8. Saikawa T, Tsumabuki S, Nakagawa M, Takakura T, Tamura M, Maeda T, Ito S & Ito M. QT intervals as an index of high serum calcium in hypercalcemia. Clinical Cardiology 1988 11 75-78. (doi:10.1002/clc.4960110205)
9. Napolitano C, Bloise R, Monteforte N & Priori SG. Sudden cardiac death and genetic ion channelopathies: Long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation 2012 125 2027-2034. (doi:10.1161/ CIRCULATIONAHA.111.055947)
10. Zhang Y, Post WS, Dalal D, Blasco-Colmenares E, Tomaselli GF & Guallar E. QT-interval duration and mortality rate: Results from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 2011 171 1727-1733. (doi:10. 1001/archinternmed.2011.433)
11. Nappi S, Saha H, Virtanen V, Limnell V, Sand J, Salmi J & Pasternack A. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology 2000 93 229-233. (doi:10.1159/ 000007031)
12. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J & Niederle B. Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. Journal of Clinical Endocrinology and Metabolism 1997 82 106-112. (doi:10.1210/jc.82.1.106)
13. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F & Borretta G. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clinical Endocrinology 1999 50 321-328. (doi:10.1046/j.1365-2265. 1999.00651.x)
14. Nilsson IL, Aberg J, Rastad J & Lind L. Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 2000 128 895-902. (doi:10.1067/msy.2000.110240)
15. Curione M, Amato S, Di Bona S, Petramala L, Cotesta D & Letizia C. Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism. International Journal of Cardiology 2010 141 201-202. (doi:10.1016/j.ijcard. 2008.11.067)
16. Curione M, Letizia C, Amato S, Di Bona S, Di Fazio F, Minisola S, Mazzuoli G & D'Erasmo E. Increased risk of cardiac death in primary hyperparathyroidism: What is a role of electrical instability? International Journal of Cardiology 2007 121 200-202. (doi:10.1016/j.ijcard.2006.08.072)
17. Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M & Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism.World Journal of Surgery 2003 27 216-222. (doi:10.1007/s00268-002-6589-9)
18. WalkerMD, Rundek T, HommaS, Ditullio M, Iwata S, Lee JA, Choi J, Liu R, Zhang C, McMahon DJ et al. Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism. European Journal of Endocrinology 2012 167 277-285.
19. Osto E, Fallo F, Pelizzo MR, Maddalozzo A, Sorgato N, Corbetti F, Montisci R, Famoso G, Bellu R, Luscher TF et al. Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 2012 126 1031-1039. (doi:10.1161/CIRCULATIONAHA. 111.081307)
20. Bollerslev J, Rosen T, Mollerup CL, Nordenstrom J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009 94 2255-2261. (doi:10.1210/jc.2008- 2742)
21. Ishay A, Herer P & Luboshitzky R. Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism. Endocrine Practice 2011 17 584-590. (doi:10.4158/EP10321.OR)
22. Pepe J, Petrucci MT, Nofroni I, Fassino V, Diacinti D, Romagnoli E & Minisola S. Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. British Journal of Haematology 2006 134 485-490. (doi:10.1111/j.1365-2141.2006.06217.x)
23. Maggio D, Cherubini A, Lauretani F, Russo RC, Bartali B, Piereandrei M, Ruggiero C, Macchiarulo MC, Giorgino R, Minisola S et al. 25(OH)D serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2005 60 1414-1419. (doi:10.1093/gerona/60.11.1414)
24. Carnevale V, Dionisi S, Nofroni I, Romagnoli E, Paglia F, De Geronimo S, Pepe J, Clemente G, Tonnarini G & Minisola S. Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clinical Chemistry 2004 50 626-631. (doi:10.1373/clinchem. 2003.026328)
25. Cockcroft DW& Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 31-41. (doi:10.1159/ 000180580)
26. Caldwell G, Kellett HA, Gow SM, Beckett GJ, Sweeting VM, Seth J & Toft AD. A new strategy for thyroid function testing. Lancet 1985 1 1117-1119. (doi:10.1016/S0140-6736(85)92429-8)
27. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography 2005 18 1440-1463. (doi:10.1016/j.echo.2005.10.005)
28. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG et al. ACC/AHA 2002 guideline update for exercise testing: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002 106 1883-1892. (doi:10.1161/01.CIR.0000034670. 06526.15)
29. Malfatto G, Zaza A & Facchini M. Different effects of antiarrhythmic drugs on the rate-dependency of QT interval: A study with amiodarone and flecainide. Journal of Cardiovascular Pharmacology 2007 50 535-540. (doi:10.1097/FJC.0b013e3181451473)
30. Bazzet HD. An analysis of the time relations of electrocardiograms. Heart 1920 7 353-370.
31. Nishime EO, Cole CR, Blackstone EH, Pashkow FJ & Lauer MS. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. Journal of the American Medical Association 2000 284 1392-1398. (doi:10. 1001/jama.284.11.1392)
32. Cole CR, Blackstone EH, Pashkow FJ, Snader CE & Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. New England Journal of Medicine 1999 341 1351-1357. (doi:10.1056/NEJM199910283411804)
33. Bilezikian JP, Khan AA, Potts JT Jr & on behalf of the Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 335-339. (doi:10.1210/ jc.2008-1763)
34. Gill JS, Baszko A, Xia R,Ward DE & Camm AJ. Dynamics of the QT interval in patients with exercise-induced ventricular tachycardia in normal and abnormal hearts. American Heart Journal 1993 126 1357-1363. (doi:10.1016/0002-8703(93)90534-G)
35. Mayuga KA, Parker M, Sukthanker ND, Perlowski A, Schwartz JB & Kadish AH. Effects of age and gender on the QT response to exercise. American Journal of Cardiology 2001 87 163-167. (doi:10.1016/S0002-9149(00)01309-6)